Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Voices of Experience: Attitudes and Opinions of Recipients of Unsupervised Injectable Opiate Treatment in the Northwest of England

To describe the views and experiences of drug users receiving unsupervised injectable opiate treatment (IOT) for opiate addiction
Original research | 2009
Safer supply, About PWUD, Outcomes, Crime, Social benefits

Community based low threshold substance use services: Practitioner approaches and challenges

To explore the efficacy and challenges of delivering low threshold substance use services within a community setting, with particular consideration of practitioner approaches
Report | 2016
Evidence base, Wrap-around services, About prescribers, Social services, Barriers and enablers, Outcomes

Could a drug-checking service increase intention to use ecstasy at a festival?

Calls to provide sanctioned drug-checking (pill testing) at Australian music festivals have been met with resistance from most governments due to concerns that such services would increase use of ecst
Original research | 2021
Evidence base, Harm reduction, Hesitancy of prescribers , Advocacy, Illegal drugs, Drug checking

Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets

Examine contaminants and filtration methods for injecting crushed tablets of slow-release morphone
Original research | 2009
Harm reduction, Safer supply, About PWUD, Injecting drugs

Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic – is an update of legal restrictions warranted?

In light of the COVID-19 pandemic, the Swiss Federal Council provisionally adapted its policy, allowing for longer prescriptions of take-home diacetylmorphine.

Original research | 2021
Evidence base, Policy/Regulatory, Safer supply, About prescribers, About PWUD, Barriers and enablers, Carries/take-home doses

Harm Reduction Satellite Sites: A Guide for Operating Harm Reduction Hubs from the Homes of People Who Use Drugs

This program guide was developed based on our experiences at two Toronto-based community health centres developing Satellite site programming out of the homes of people who use drugs.
Guidelines | 2020
Overdose, Harm reduction, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Barriers and enablers, Peer/PWLLE program involvement

Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs

This ethno-epidemiological study was undertaken in Vancouver, Canada to explore how the social-structural dynamics within hospitals function to produce discharges against medical advice among PWID.
Original research | 2014
Withdrawal, Harm reduction, Policy/Regulatory, About PWUD, Illegal drugs, SCS/OPS, Hospitals

Injection of Pharmaceuticals Designed for Oral Use: Harms Experienced and Effective Harm Reduction Through Filtration. Non-medical and illicit use of psychoactive drugs

Since these products are designed for oral administration, they can contain excipients (ingredients other than the drug) which are poorly soluble, resulting in suspension of particles in the injection
Book | 2017
Harm reduction, Safer supply, About PWUD, Injecting drugs

Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy

Assess the effect of and recommendations for urine drug screening on health outcomes for persons with OUD who receive OAT
Lit review | 2018
Evidence base, Policy/Regulatory, Safer supply

Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada

This study examines peoples’ motivations for accessing HDM/DAM treatment and situates these within the social and structural context that shapes treatment delivery by employing the concept of structur
Original research | 2020
Harm reduction, Safer supply, Equity, About PWUD, Social benefits

Not what the doctor ordered: Motivations for nonmedical prescription drug use among people who use illegal drugs

This study provides further evidence of the harm reducing motives for Nonmedical Prescription Drug Use (NMPDU) among people who use illegal drugs in community and prison settings in Wales, UK.
Original research | 2020
Withdrawal, Safer supply, Equity, Advocacy, About PWUD, Legal system/law enforcement, Substitution/OAT, Diversion

Opioid agonist treatment and the process of injection drug use initiation

Preliminary evidence suggests that OAT may disrupt the social communicability of injection drug use (IDU) practices by established PWID.
Original research | 2019
Evidence base, Safer supply, Illegal drugs

Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities

The aim of this study was to examine perceptions of (supervised) injectable opioid agonist treatment (iOAT) (described as ‘an opioid similar to heroin self-injected at a clinic several times a day’) a
Original research | 2020
Policy/Regulatory, Safer supply, About PWUD, Barriers and enablers

Portrait du matériel d'injection et d'inhalation de drogues remis par les directions de santé publique aux centres d'accès du Québec : 2016-2017 à 2018-2019

Présente une analyse comparative des quantités de matériel remis par les directions de santé publique aux 1 239 centres d’accès au matériel d’injection.
Report | 2021
Harm reduction, Outcomes, Illegal drugs, Social benefits

Prescribing drug of choice to opiate dependent drug users: A comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic

Compare outcomes between prescribed methadone and heroin
Original research | 2001
Evidence base, Safer supply, Outcomes, Crime, Substitution/OAT

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

To understand which durations of prolonged-release buprenorphine patients prefer
Original research | 2019
Evidence base, Wrap-around services, Safer supply, Social services, Barriers and enablers, Crime, Substitution/OAT, Social benefits, Stigma

Saving Lives. Changing Lives. Findings from an Evaluation of London’s Temporary Overdose Prevention Site (TOPS)

Process and outcome evaluation of the site's first six months
Report | 2019
Overdose, Harm reduction, Wrap-around services, Advocacy, About prescribers, About PWUD, Social services, Barriers and enablers, Outcomes, Crime, Illegal drugs, Drug checking, Stigma, SCS/OPS

The community impact of RIOTT, a medically supervised injectable maintenance clinic in south London

Investigates the impact on the local community of a Medically Supervised Injectable Maintenance Clinic
Original research | 2010
Crime, Illegal drugs, SCS/OPS

The virtual disappearance of injectable opioids for heroin addiction under the ‘British System’

Injectable opioids were prescribed unsupervised under the ‘British System’ for heroin dependence.
Original research | 2010
Policy/Regulatory

A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here

Looks at which medications are used to treat opioid addiction and the reasons influencing their choice
Commentary | 2016
Evidence base, Policy/Regulatory, About prescribers

Affiner votre recherche

Mots clés
Format
Région